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Abstract
The tumor suppressor epithelial isoform of the fibroblast growth factor receptor 2 (FGFR2b) induces human
keratinocyte early differentiation. Moreover, protein kinases C (PKCs) are known to regulate the differentiation program
in several cellular contexts, including keratinocytes. Therefore, in this paper we propose to clarify if FGFR2b could play
a role also in the late steps of keratinocyte differentiation and to assess if this receptor-induced process would
sequentially involve PKCδ and PKCα isoforms. Immunofluorescence, biochemical, and molecular approaches,
performed on 2D cultures or 3D organotypic rafts of human keratinocytes overexpressing FGFR2b by stable
transduction, showed that receptor signaling induced the precocious onset and an accelerated progression of
keratinocyte differentiation, indicating that FGFR2b is a crucial regulator of the entire program of keratinocyte
differentiation. In addition, the use of specific inhibitors and gene silencing approaches through specific siRNA
demonstrated that PKCδ controls the onset of FGFR2b-triggered differentiation, while PKCα plays a role restricted to
the terminal stages of the process. Molecular analysis revealed that the two PKC isoforms sequentially act via induction
of KLF4 and DLX3, two transcription factors linked by negative loops to p63, suggesting that p63 would represent the
hub molecule at the crossroad of an intricate signaling network downstream FGFR2b, involving multiple PKC-induced
transcription factors.
Introduction
The family of fibroblast growth factor receptors
(FGFRs) includes four transmembrane receptor tyrosine
kinases (FGFR1–4) involved in the regulation of crucial
biological processes, such as proliferation, migration,
survival, and differentiation1,2. Alternative splicing of the
extracellular IgIII loop in FGFR1-3 generates epithelial
FGFRb and mesenchymal FGFRc isoforms, determining
ligand specificity1. Deregulation of the expression and
signaling of FGFRs is well known to play oncogenic
roles3,4. In the case of FGFR2, altered isoform switching
and aberrant expression of the mesenchymal FGFR2c
isoform in epithelial cells induce epithelial-mesenchymal
transition (EMT)5,6 and are involved in cancerogenesis7,8,
while the epithelial FGFR2b variant appears to exert
tumor suppressive functions9,10.
In agreement with the knowledge of the key role played
by FGFR2b in the regulation of skin homeostasis11–13,
studies from our group have demonstrated that FGFR2b
is up-regulated in epidermal suprabasal layers14 and is
able to induce early differentiation in normal human
keratinocytes15. We have also suggested that FGFR2b
exerts its differentiative function via the repression of
p6316, a transcription factor whose down-modulation
represents the main molecular mechanism known to drive
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early differentiation of stratified epithelia17. Although the
role of FGFR2b in early stages of keratinocyte differ-
entiation has been deeply investigated, its involvement in
the later steps of the process still remains debated18–20
and to be clarified.
With the aim to analyze the possible signaling candi-
dates for the regulation of FGFR2b-mediated early dif-
ferentiation, we have previously demonstrated the
involvement of the PI3K/AKT pathway15. However, the
keratinocyte differentiation is a complex program
implying several steps of coordinated molecular events
driven by an intricate signaling network; therefore, to
verify if additional pathways downstream FGFR2b could
participate to such network, we focused our attention on
protein kinases C (PKCs) and in particular to the PKCδ
and PKCα isoforms. In fact, these signaling substrates
are involved in FGFR2-mediated differentiation in the
bone context21,22 and it has been proposed that PKCδ
and PKCα could regulate keratinocyte differentiation23,
during which they appear to exert temporally and spa-
tially distinct roles.
A function in the onset of keratinocyte differentiation
has been proposed for PKCδ23–29, which is expressed
starting from the basal layer of epidermis where, upon
activation, causes hemidesmosomal disassembly and basal
cell migration upward into the suprabasal layers30,31. At
the level of transcriptional control, PKCδ induces the
early differentiation marker desmoglein-1 (DSG1)26.
Moreover, recent studies highlighted that PKCδ, through
the induction of the transcription factor Kruppel-like
factor 4 (KLF4), up-modulates p21 and the intermediate
differentiation marker involucrin (INV)32 triggering cell
cycle arrest and differentiation, respectively28,29.
On the other hand, a role in epidermal late differ-
entiation has been proposed for PKCα. In fact, PKCα
expression is restricted to epidermal suprabasal layers23
and its inhibition or depletion represses the expression of
the late differentiation markers filaggrin (FIL) and loricrin
(LOR)32, while the early/intermediate differentiation
markers keratin 1 (K1), K10, and INV32 appear sub-
stantially unaffected25,27,33–36. Distal-less homeobox 3
(DLX3) could be the molecular player acting downstream
PKCα in keratinocyte differentiation:36 this transcription
factor is expressed in the suprabasal layers and is involved
in the induction of FIL and LOR, as well as in the epi-
dermal barrier formation37–39.
Based on these assumptions, here we propose to clarify
if FGFR2b could play a general role in the control of the
entire program of keratinocyte differentiation and to
assess if the possible function of FGFR2b in the different
steps of the process might be regulated by a signaling
network sequentially involving PKCδ and PKCα iso-
forms and their respective downstream transcription
factors.
Results
FGFR2b controls not only the early, but also the late steps
of keratinocyte differentiation
Studies from our group have demonstrated that
FGFR2b expression and activation promote keratinocyte
early differentiation15,16. Here, in order to investigate if
FGFR2b might also control the later stages of differ-
entiation, we first analyzed the impact of the receptor
signaling on the expression and distribution throughout
the epidermal layers of two distinct markers of the most
early or the most late differentiation steps: the early
cytokeratin K1 and the terminal differentiation FIL. For
this purpose we reproduced in vitro the keratinocyte
differentiation program occurring in vivo, using 3D
organotypic skin equivalents prepared with human
HaCaT keratinocytes40 stably transduced with pBp-
FGFR2b retroviral constructs or with empty pBp vector
as negative control6. In fact, through this model of
receptor-overexpressing cells we are able to force the
system toward the differentiated phenotype. The orga-
notypic cultures were left untreated or stimulated with
FGF7 as reported in Materials and methods section.
Quantitative immunofluorescence analysis showed that,
in pBp rafts, the K1 signal was visible in all suprabasal
layers (Fig. 1a, left panels) and increased by FGF7 stimu-
lation (Fig. 1a, left panels), as expected15. Interestingly,
HaCaT pBp-FGFR2b rafts showed, besides the enhance-
ment of K1 staining (Fig. 1a, left panels), its appearance
already in the basal layer (Fig. 1a, left panels), suggesting
the precocious onset of early differentiation. Parallel
evaluation of FIL expression showed that, as expected32,
its granular staining appeared confined in the uppermost
layers of pBp skin equivalents (Fig. 1a, right panels) and it
was significantly increased by FGF7 stimulation (Fig. 1a,
right panels). In addition, FGFR2b overexpression
induced a general enhancement of this staining and its
appreciable appearance starting from lower layers of the
rafts (Fig. 1a, right panels), suggesting an accelerated
progression also throughout the terminal steps of differ-
entiation. As previously reported41, the higher staining of
the analyzed markers in pBp-FGFR2b untreated organo-
typic cultures respect to the corresponding unstimulated
pBp rafts would be ascribed to the already acquired
enhanced differentiated phenotype of the FGFR2b clones
during their growth in complete medium before starva-
tion. Our observations were also validated at molecular
level by real time RT-PCR analysis, demonstrating that
the expression of early (K10 and DSG1), intermediate
(INV, transglutaminase-1: TGM1) and late differentiation
marker (LOR) genes were significantly increased in
response to FGF7 and particularly in cells overexpressing
FGFR2b (Fig. 1b). Thus, FGFR2b and its signaling appear
to play a positive role on the entire program of kerati-
nocyte differentiation.
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Fig. 1 FGFR2b expression and signaling play a positive role on the entire program of keratinocyte differentiation. Organotypic skin
equivalents of HaCaT pBp and pBp-FGFR2b clones, prepared as reported in Materials and methods section, were grown in complete medium and left
untreated or stimulated with FGF7 for the last 4 days. a Quantitative immunofluorescence analysis shows that, in pBp rafts, K1 staining is visible in all
suprabasal layers and it is increased by FGF7 stimulation. In HaCaT pBp-FGFR2b raft K1 staining is enhanced and detectable already in the basal layer.
Parallel evaluation of FIL expression shows that the its granular staining appears confined in the uppermost layers of pBp skin equivalents and it is
significantly increased by FGF7 stimulation. FGFR2b overexpression induces a general enhancement of the staining and its appreciable appearance
starting from lower layers of the rafts. Quantitative analysis of the fluorescence intensity was performed as described in Materials and methods and
results sections are expressed as fold increase respect to pBp values ± SE. Student’s t test was performed and significance levels have been defined as
p < 0.05: *p < 0.0001 vs the corresponding FGF7-unstimulated cells; **p < 0.0001 vs the corresponding pBp cells. Bar: 25 μm. b Real time RT-PCR
analysis shows that mRNA expression of the early (K10 and DSG1), intermediate (TGM1 and INV) and late differentiation (LOR) markers are significantly
increased upon FGF7 stimulation, particularly in pBp-FGFR2b rafts. Results are expressed as mean values ± SD. Student’s t test was performed and
significance levels have been defined as p < 0.05: *p < 0.05, and ***p < 0.005 vs the corresponding FGF7-unstimulated cells; **p < 0.05 vs the
corresponding pBp cells
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In order to analyze in detail this role, we “dissected”
in vitro the process using HaCaT pBp and HaCaT pBp-
FGFR2b cultures grown until confluence, the step that
precedes the shift from the basal to suprabasal layer, or up
to post-confluence, the step that mimics the late differ-
entiation and stratification40. Cells were then left
untreated or stimulated with FGF7, as reported in Mate-
rials and methods section, and Western blot analysis was
performed to estimate the expression of a wide selection
of differentiation markers. Results showed that, in con-
fluent conditions, a clear up-regulation of the early dif-
ferentiation markers K1 and DSG1 and of the
intermediate differentiation marker INV was induced by
FGF7, particularly in pBp-FGFR2b cells (Fig. 2a). In
addition, an opposite behavior was observed for the basal
marker β1-integrin42, whose expression appeared strongly
decreased in HaCaT pBp-FGFR2b in response to ligand
stimulation (Fig. 2a). Finally, in agreement with their
similarities with basal/differentiating keratinocytes, no
appreciable levels of the late differentiation marker FIL
and LOR were found in all confluent HaCaT clones
(Fig. 2a). On the other hand, the shift to post-confluence
strongly increased the expression of all the differentiation
markers (Fig. 2b), making their FGF7-induced modulation
less evident compared to the corresponding confluent
cells (Fig. 2b). Moreover, as already observed in 3D
organotypic cultures, pBp-FGFR2b cells showed a higher
differentiated phenotype compared to pBp cultures also in
the absence of FGF7 stimulation, which can be ascribed to
the enhanced differentiation acquired during the growth
in complete medium before starvation. The observed
progressive modulation in response to FGF7 of early/
intermediate and LORs in confluent and post-confluent
cultures of HaCaT clones, respectively, was also
a
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Fig. 2 FGFR2b has a sequential role in distinct steps of the keratinocyte differentiation. HaCaT pBp and HaCaT pBp-FGFR2b clones grown up
to confluence or post-confluence were left untreated or stimulated with FGF7 as reported in Materials and methods section. a Western blot analysis
shows that in confluent conditions the levels of K1, DSG1, and INV are increased upon FGF7 stimulation particularly in pBp-FGFR2b cells, while no
appreciable levels of FIL and LOR are visible in these cells. In addition, the expression of β1-integrin appears strongly decreased in HaCaT pBp-FGFR2b
in response to ligand stimulation. b In post-confluence conditions all the early/intermediate differentiation markers appear increased making their
FGF7-induced modulation less evident compared to the corresponding confluent cells. In contrast, FIL and LOR are detectable and they appear up-
regulated in response to FGF7 stimulation, particularly in cells overexpressing FGFR2b. The equal loading was assessed with anti-ACTIN and anti-
TUBULIN antibodies. For densitometric analysis the values from a representative of three independent experiments are reported
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confirmed at the mRNA transcript level (Supplementary
Figure S1).
PKCδ and PKCα signaling play sequential roles in FGFR2b-
triggered keratinocyte differentiation
Searching for the possible downstream candidates that
could be alternatively involved in FGFR2b-mediated early
or late differentiation, we focused our attention on PKCδ
and PKCα isoforms, since they have been proposed to
exert distinct roles in keratinocyte differentiation23.
Since PKCδ isoform has been proposed to be specifi-
cally implicated in the onset of the process23–29, we first
investigated its contribution in FGFR2b-induced early
differentiation taking advantage of the specific inhibitor
rottlerin (PKCδi), previously used to demonstrate the
involvement of PKCδ in FGF/FGFR signaling pathways21,
as well as in FGFR2b-triggered autophagy43. The inhibitor
efficiency was confirmed testing its ability to decrease the
basal, as well as the FGF7-induced, phosphorylation of
PKCδ at the autophosphorylation site Serine 64544
(Fig. 3a, left panel), but not that of PKCα at the autop-
hosphorylation site Serine 65745 (Fig. 3a, left panel). Then
we analyzed the impact of this inhibitor on the modula-
tion of early/intermediate differentiation markers induced
by FGFR2b and its signaling in confluent cultures. Wes-
tern blot analysis clearly showed that PKCδi exerted a
strong repressive effect on the K1, DSG1, and INV
increase induced by FGF7, which was particularly evident
in FGFR2b overexpressing clones (Fig. 3a, right panel).
Indeed, in agreement with the proposed general role of
PKCδ in keratinocyte early differentiation23, this inhibi-
tory effect, even if less pronounced, was also detectable in
cells not stimulated with FGF7 (Fig. 3a, right panel).
However, to exclude the possibility of the establishment of
an autocrine signaling due to endogenous production of
FGF7, which could explain the phenotype displayed by
unstimulated FGFR2b clones, we performed real time RT-
PCR analysis: FGF7 mRNA was undetectable in both
HaCaT clones also after PKC signaling shut-off (data not
shown). To unequivocally demonstrate the role of PKCδ
on early differentiation, we performed its specific deple-
tion by siRNA transfection. To this aim, HaCaT clones
were transfected with PKCδ siRNA or with an unrelated
siRNA as control. The efficiency of protein depletion was
verified through Western blot analysis (Fig. 3b, left panel).
Transfected cells were grown until confluence and left
untreated or stimulated with FGF7 as above. Western blot
analysis showed that PKCδ silencing strongly counter-
acted the increase of K1, DSG1, and INV in response to
FGF7 (Fig. 3b, right panel). In addition, similarly to what
observed after the pharmacological inhibition, PKCδ
depletion appeared to slightly affect also the basal level of
the markers (Fig. 3b, right panel), confirming its general
role in the control of early differentiation.
These findings were also validated at the mRNA tran-
script level by real time RT-PCR analysis, confirming that,
in both HaCaT pBp and pBp-FGFR2b confluent cultures,
the block of PKCδ activity by PKCδi (Fig. 3c) or protein
depletion by specific siRNA (Fig. 3d) strongly decreased
FGF7-induced, as well as basal expression, of K10, DSG1,
and INV. The results obtained were strengthened by
quantitative immunofluorescence analysis (Supplemen-
tary Figure S2, left and right panels), in which we intro-
duced also the inhibitor of AKT (AKTi)15,43,46, in order to
interfere with the additional FGFR2b downstream path-
way previously identified by us as involved in keratinocyte
early differentiation15, or the MEK1/2 inhibitor (MEK1/
2i), as negative control, since we have recently observed
that this pathway did not appear to be involved in the
process (Nanni et al., manuscript in preparation). In fact,
while the role played by AKT signaling appears to be
restricted to some aspects of FGFR2b-induced early steps
of the process, PKCδ emerges as hub signaling down-
stream FGFR2b regulating the entire early differentiation.
Because PKCα isoform has been proposed to be a sig-
naling substrate crucial for the later steps of keratinocyte
differentiation23,25,27,33–36, we investigated its possible
contribution in FGFR2b-induced terminal steps of the
process. To this aim the effects of PKCα inhibition were
analyzed in post-confluent cultures of HaCaT clones
using the specific inhibitor Go6976 (PKCαi)36. The effi-
ciency of PKCαi was assessed by Western blot analysis,
performed in both HaCaT pBp and pBp-FGFR2b cultures,
showing a decrease of the basal, as well as the FGF7-
induced PKCα phosphorylation at the autopho-
sphorylation site Serine 65745 (Fig. 4a, left panel), but not
that of PKCδ at the autophosphorylation site Serine 64544
(Fig. 4a, left panel). Then we investigated if PKCαi could
affect FGFR2b-induced differentiation. Western blot
analysis highlighted that PKCαi did not interfere with the
expression of the early differentiation marker K1 (Fig. 4a,
right panel), but it displayed a strong repressive effect on
the FGF7-induced up-modulation of the late differentia-
tion markers LOR and FIL (Fig. 4a, right panel). More-
over, also the basal level of LOR and FIL markers
expressed in cells not stimulated with FGF7 appeared
weakly dampened by PKCαi, confirming the general role
of PKCα in keratinocyte differentiation23. Similar results
were obtained by specific siRNA approaches. The effi-
ciency of protein depletion was first confirmed by Wes-
tern blot analysis (Fig. 4b, left panel). Then, the effects of
PKCα silencing showed repression of the late differ-
entiation markers LOR and FIL (Fig. 4b, right panel), but
not of the early differentiation marker K1 (Fig. 4b, right
panel) in both pBp and pBp-FGFR2b clones. The inhibi-
tory effect of either PKCα pharmacological inhibition
(Fig. 4c) and protein depletion (Fig. 4d) was also con-
firmed at the mRNA transcript level by real time RT-PCR
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Fig. 3 (See legend on next page.)
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analysis. Thus, also PKCα appears a pivotal player in
FGFR2b-triggered keratinocyte differentiation; however,
differently from PKCδ, its role appears to be specifically
restricted to the late stages of the process.
Then, in order to analyze the effect of PKCδ inhibition
on the ability of keratinocytes to progress throughout the
entire differentiation program and stratify in response to
FGFR2b activation, we again took advantage of the use of
the more complete model of organotypic cultures. HaCaT
pBp and HaCaT pBp-FGFR2b rafts were lifted to
air–liquid interface in the presence or not of PKCδi and
finally stimulated with FGF7, as above. Quantitative
immunofluorescence analysis showed that the K1 and FIL
staining, visible in both HaCaT pBp and HaCaT pBp-
FGFR2b rafts stimulated with FGF7 (Fig. 5a, upper
panels), appeared overall dampened by the presence of
PKCδi, suggesting that the entire differentiation process
induced by FGFR2b signaling was arrested by the sus-
tained inhibition of PKCδ (Fig. 5a, upper panels). In
addition, the immunostaining of K5 revealed that the
canonical distribution in the basal layer of this undiffer-
entiated/proliferating cell marker32, visible in pBp control
rafts (Fig. 5a, lower panels), disappeared in pBp-FGFR2b
skin equivalents (Fig. 5a, lower panels), confirming the
precocious onset of differentiation. However, in the pre-
sence of PKCδi, K5 staining appeared recovered and
distributed all over the rafts (Fig. 5a, lower panels).
Moreover, the parallel evaluation of Ki67 staining in both
pBp and pBp-FGFR2b rafts stimulated with FGF7 revealed
few positive cells distributed in the basal layer (Fig. 5a,
lower panels); the presence of some stained cells also in
the suprabasal layers (Fig. 5a, lower panels) is in agree-
ment with the previously described ability of FGF7 to also
sustain the residual proliferative activity of suprabasal
keratinocytes14. More interestingly, in pBp-FGFR2b raft
grown in the presence of PKCδi, several cells intensely
stained for Ki67 marker appeared homogeneously dis-
tributed in all the layers (Fig. 5a, lower panels), suggesting
sustained cell proliferation. These findings strongly indi-
cated that, as a consequence of PKCδ signaling shut-off,
keratinocytes are defective in the ability to undergo the
differentiation program maintaining a basal/proliferative
phenotype. Real time RT-PCR analysis confirmed that the
expression of both early and LORs was significantly
repressed by PKCδi (Fig. 5b). Finally, the quantitative
evaluation of the raft thickness revealed that, in pBp and
pBp-FGFR2b skin equivalents, the layers were sig-
nificantly reduced by PKCδi (Fig. 5c), further indicating
that inhibition of PKCδ induces impairment of all steps of
FGFR2b-triggered differentiation, which in turn results in
defective stratification.
The transcription factors KLF4 and DLX3, acting
downstream PKCδ and PKCα respectively, are sequentially
up-regulated by FGFR2b signaling
Since it has been recently proposed that PKCδ and
PKCα control the expression of several genes via the
induction of KLF428,29 and DLX336 respectively, we
decided to investigate the possible involvement of these
transcription factors in FGFR2b-triggered keratinocyte
differentiation. The topic was particularly appealing, since
they have been proposed to be involved in an intricate
network of loops with ΔNp6347–49, the transcription
factor whose down-modulation represents the main
molecular mechanism known to drive differentiation of
stratified epithelia17. Indeed, we have already described a
link between FGFR2b and p6316, but the molecular
mechanism underlying this interplay remains to be still
clarified. To this aim, we performed Real Time RT-PCR
analysis on HaCaT pBp and pBp-FGFR2b 3D organotypic
rafts, checking for the transcript levels of KLF4 and DLX3
and comparing them with that of p63. The results showed
a significant increase of both KLF4 and DLX3 and an
opposite decrease of p63 in response to FGF7 stimulation
(Fig. 6a), which were more evident in the rafts over-
expressing FGFR2b (Fig. 6a).
(see figure on previous page)
Fig. 3 PKCδ controls the onset of FGFR2b-triggered keratinocyte differentiation. Confluent HaCaT pBp and HaCaT pBp-FGFR2b clones were left
untreated or stimulated with FGF7 in presence or not of the PKCδ inhibitor as reported in Materials and methods section (a, c). Alternatively, HaCaT
clones were transfected with PKCδ siRNA or with an unrelated siRNA as control, and then left untreated or stimulated with FGF7 (b, d). aWestern blot
analysis confirms that PKCδ inhibitor interferes with the basal, as well as the FGF7-induced, phosphorylation of PKCδ at its autophosphorylation site
Ser645 but not with that of PKCα at its autophosphorylation site Ser657 (left panel). PKCδ inhibition induces a repressive effect on the K1, DSG1, and
INV increase induced by FGF7, which is particularly evident in FGFR2b overexpressing clones (right panel). b Western blot analysis confirms that PKCδ
silencing specifically dampened the basal, as well as the FGF7-induced, PKCδ protein level but not that of PKCα (left panel). PKCδ silencing also
strongly counteracts the increase of K1, DSG1, and INV in response to FGF7 (right panel). The equal loading was assessed with anti-PKCδ or anti-PKCα
and anti-ACTIN or anti-TUBULIN antibodies. For densitometric analysis the values from a representative of three independent experiments are
reported. c, d Real time RT-PCR analysis confirms that PKCδ inhibition (c) or depletion (d) decreases FGF7-induced, as well as basal mRNA transcript
levels, of K10 DSG1 and INV. Results are expressed as mean values ± SD. Student’s t test was performed and significance levels have been defined as
above: c *p < 0.05 vs the corresponding FGF7-unstimulated cells; **p < 0.05 vs the corresponding pBp cells; ***p < 0.05 vs the corresponding PKCδ
inhibitor-untreated cells; d *p < 0.05 vs the corresponding FGF7-unstimulated cells; **p < 0.05 vs the corresponding pBp cells; ***p < 0.05 and ****p <
0.005 vs the corresponding control siRNA cells
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Fig. 4 (See legend on next page.)
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Then, to verify if KLF4 and DLX3 up-regulation could
display a sequential trend during FGFR2b-induced kera-
tinocyte differentiation, we analyzed their possible mod-
ulation in confluent and post-confluent clones stimulates
with FGF7 as above. The results showed that KLF4 up-
regulation was mainly appreciable in confluent clones
(Fig. 6b), while DLX3 induction was detectable only in
post-confluent cultures (Fig. 6b). As expected, the
induction of KLF4 in confluent cells as well as that of
DLX3 in post-confluent cells were significantly counter-
acted by PKCδi and PKCαi, respectively (Fig. 6b), further
confirming the connection of each PKC signaling with the
corresponding transcription factor. Moreover, similarly to
what observed for KLF4 and consistently with its well-
established role in FGFR2b-induced onset of differentia-
tion15,16, p63 repression in response to FGF7 was more
evident in confluent cells and impaired only by PKCδi
(Fig. 6b). Being p63 a direct negative regulator of KLF4 in
normal human keratinocytes49, its strong repression
observed in confluent cells may represent the molecular
mechanism through which FGFR2b-triggered PKCδ sig-
naling would induce KLF4 and consequently the onset of
keratinocyte differentiation. These results suggest that the
alternative induction of KLF4 and DLX3 in FGF7-
stimulated confluent and post-confluent cells, respec-
tively, might reflect the sequential activation of their
upstream activators PKCδ and PKCα during the early and
late steps of FGFR2b-induced differentiation.
Discussion
Because of its hypothesized role as a tumor suppressor
in vitro and in vivo9,10, forced modulation of FGFR2b
could be a winning strategy to revert important aspects of
the malignant phenotype in carcinoma cells, including
loss of cell differentiation. However, in the physiological
context of normal human keratinocytes, despite the
numerous evidences emphasizing the role of FGFR2b in
the enhancement of early differentiation, only few and
contrasting reports appear to suggest its possible invol-
vement in the later stages of this process18–20. Therefore,
here we first analyzed the impact of the receptor signaling
on the induction of terminal differentiation in 3D orga-
notypic rafts and 2D cultures of human keratinocytes
engineered to stably overexpress FGFR2b. The results
obtained clearly indicated that, particularly when FGFR2b
is overexpressed, the receptor signaling not only induces a
precocious onset of the early differentiation markers, but
also enhances the expression and accelerates the appear-
ance of the terminal markers. These findings strongly
suggest a key role of FGFR2b in the regulation of the
entire differentiation program.
Then, in order to analyze the signaling players down-
stream FGFR2b possibly involved in keratinocyte differ-
entiation, we focused on PKCδ and PKCα isoforms, at the
light of previous evidences showing their sequential role
in the regulation of the different steps of the process23. To
the aim to “dissect” in vitro the differentiation steps, cells
were grown until confluence or up to post-confluence.
Taking advantage of the use of specific substrate inhibi-
tors and siRNA interference, we highlighted that PKCδ
signaling appears to drive the early molecular events,
while PKCα regulates the late ones, of FGFR2b-triggered
keratinocyte differentiation. Given the role of PKCδ in the
onset of the process, we used the organotypic cultures to
analyze the impact of its inhibition on the ability of ker-
atinocytes to terminally differentiate and stratify in
response to ligand-mediated activation of FGFR2b: we
demonstrated that PKCδ signaling shut-off was sufficient
to block the entire differentiation program, inducing
retention of undifferentiated/basal features and defective
stratification. Interestingly, these rafts also maintained a
sustained cell proliferation throughout all the layers that
could be explained by the previously described ability of
FGFR2b to not only promote the differentiation pro-
gram15, but also sustain the residual proliferative activity
of suprabasal, differentiating keratinocytes14. Overall, the
(see figure on previous page)
Fig. 4 PKCα is required for FGFR2b-induced terminal stages of keratinocyte differentiation. Post-confluent HaCaT pBp and HaCaT pBp-FGFR2b
cells were left untreated or stimulated with FGF7 in presence or not of the PKCα inhibitor as reported in Materials and methods section (a, c).
Alternatively, HaCaT clones were transfected with PKCα siRNA or with an unrelated siRNA as control, transfected cells were grown until post-
confluence and left untreated or stimulated with FGF7 as above (b, d). a Western blot analysis shows that PKCα inhibitor decreases the basal, as well
as the FGF7-induced, PKCα phosphorylation, but not that of PKCδ phosphorylation (left panel). PKCα inhibitor does not interfere with the K1
expression, but it displays a repressive effect on the FGF7-induced up-modulation of LOR and FIL (right panel). b Western blot analysis confirms that
PKCα silencing specifically dampened the basal, as well as the FGF7-induced, PKCα protein level but not that of PKCδ (left panel). PKCα silencing also
strongly counteracts the increase of LOR and FIL but not that of K1 in response to FGF7 (right panel). The equal loading was assessed with anti-PKCδ
or anti-PKCα and anti-ACTIN or anti-TUBULIN antibodies. For densitometric analysis the values from a representative of three independent
experiments are reported. c, d Real time RT-PCR analysis confirms that PKCα inhibition (c) or depletion (d) decreases FGF7-induced, as well as basal
mRNA transcript levels, of LOR and FIL but it does not affect K10 expression. Results are expressed as mean values ± SD. Student’s t test was
performed and significance levels have been defined as above: *p < 0.05 vs the corresponding FGF7-unstimulated cells; **p < 0.05 vs the
corresponding pBp cells; NS and ***p < 0.05 vs the corresponding PKCα inhibitor-untreated cells; d *p < 0.05 vs the corresponding FGF7-unstimulated
cells; **p < 0.05 vs the corresponding pBp cells; NS, ***p < 0.05 and ****p < 0.005 vs the corresponding control siRNA cells
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Fig. 5 (See legend on next page.)
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phenotypic features derived by PKCδ signaling shut-off
indicate that the inhibition of this signaling pathway alone
is sufficient to impair the balance between cell prolifera-
tion and differentiation controlled by FGFR2b. On the
other hand, we can not exclude the contribution of the
epidermal growth factor receptor (EGFR) in such
increased cell proliferation: in fact, the antagonistic role of
FGFR2b and EGFR in epithelial cells has been previously
described by our group50. While FGFR2b is up-regulated
during the shift from the basal to the suprabasal layers,
EGFR mainly displays a basal distribution and its ligand-
dependent activation triggers cell proliferation. In addi-
tion, it has been also proposed that FGF7/KGF treatment
may induce endogenous synthesis of the EGFR ligand
TGFα.51 In any case, these results are in agreement with
the widely described role of PKCδ as tumor suppressor,
which is down-regulated in squamous cell carcinomas
(SCCs)52,53.
Concerning the molecular effectors acting downstream
PKC isoforms, our results showed that, in agreement with
previous reports28,29,36, PKCδ and PKCα isoforms act via
the induction of the downstream transcription factors
KLF4 and DLX3, respectively. In fact, the expression of
both KLF4 and DLX3 was clearly induced in response to
FGF7, particularly in rafts or cell cultures overexpressing
FGFR2b. Interestingly, in cultures grown at different cell
densities to mimic the various steps of differentiation, we
found that KLF4 up-regulation was mainly appreciable in
confluent cells, while DLX3 induction was detectable only
in post-confluent cultures. These sequential trends of
induction could reflect the progressive involvement of
their upstream inductors PKCδ and PKCα in the distinct
stages (early and late, respectively) of differentiation.
Finally, we also decided to compare the modulation of
KLF4 and DLX3 with that previously described for p63
and induced by FGFR2b signaling16,41. In fact, the
FGFR2b/p63 crosstalk appears to be central in the
homeostatic balance between keratinocyte proliferation
and differentiation and its impairment, due to out-of-
context appearance of FGFR2c, leads to loss of the dif-
ferentiated phenotype and acquisition of tumorigenic
features41. For this reason, to identify the molecular
players contributing to the regulation of this crosstalk
seems to represent a very urgent and important goal.
Indeed, both KLF4 and DLX3 have been proposed to be
involved in negative loops with p63:48,49 consistent with
these assumptions, we observed that they displayed
opposite modulations compared to p63. Interestingly, the
up-regulation of KLF4 appeared more appreciable in
confluent cells, the same culture condition in which the
down-regulation of p63 was more evident: this simulta-
neous detection of p63 down-regulation and KLF4
induction mainly in confluent cells strongly suggests that
they take place in the same step of the differentiation
program, and possibly during the shift between the basal
to the suprabasal layer. These observations, together with
the recent evidence of a possible direct role of PKCδ in
p63 down-regulation54, allowed us to speculate that the
down-regulation of p63 could represent the molecular
mechanism through which FGFR2b and its downstream
PKCδ signaling could induce the up-regulation of KLF4
and consequently the onset of keratinocyte differentiation.
Materials and methods
Cells and treatments
The human keratinocyte cell line HaCaT40, stably
overexpressing FGFR2b (pBp-FGFR2b) or the empty
vector (pBp) and generated as previously described6, were
cultured in Dulbecco’s modified Eagle’s medium
(DMEM), supplemented with 10% fetal bovine serum
(see figure on previous page)
Fig. 5 PKCδ signaling shut-off blocks the entire differentiation program and induces defective stratification in keratinocytes. Organotypic
skin equivalents of HaCaT pBp and pBp-FGFR2b clones, prepared as reported in Materials and methods section, were lifted to air–liquid interface in
the presence or not of PKCδ inhibitor and finally stimulated with FGF7 as above. a Quantitative immunofluorescence analysis shows that K1 and FIL
staining, visible in both HaCaT pBp and HaCaT pBp-FGFR2b rafts stimulated with FGF7, appears overall impaired by the presence of PKCδ inhibitor
(upper panels). In addition, K5 signal, visible in the basal layer of pBp rafts, disappears in pBp-FGFR2b skin equivalents while it is recovered and
distributed all over the pBp-FGFR2b rafts by the presence of PKCδ inhibitor (lower panels). Parallel evaluation of the nuclear proliferation marker Ki67
reveals the presence of few positive cells distributed in the basal layer and randomly throughout the suprabasal layers in pBp rafts and FGFR2b rafts
stimulated with FGF7 (lower panels). In pBp-FGFR2b raft grown in the presence of PKCδi, several cells intensely stained for Ki67 marker are visible in
all the layers (lower panels). Quantitative analysis of the fluorescence intensity and of the percentage of Ki67 positive cells were performed as
described in Materials and methods and results sections are expressed as fold increase respect to pBp values ± SE. Student’s t test was performed and
significance levels have been defined as above: *p < 0.0001 vs the corresponding PKCδ inhibitor-untreated cells; NS and **p < 0.0001 vs the
corresponding pBp cells. Bar: 25 μm. b Real time RT-PCR analysis confirms that, in pBp and pBp-FGFR2b rafts stimulated with FGF7, the expression of
K10, DSG1, and LOR is significantly repressed by PKCδ inhibitor. Results are expressed as mean values ± SD. Student’s t test was performed and
significance levels have been defined as above: *p < 0.05 vs PKCδ inhibitor-untreated cells; **p < 0.05 vs the corresponding pBp cells. c Quantitative
evaluation of the raft thickness shows that the layers of pBp and pBp-FGFR2b skin equivalents are significantly reduced by the presence of PKCδ
inhibitor. Quantitative analysis of the raft thickness was expressed as µm mean ± SD from three independent experiments. Student’s t test was
performed and significance levels have been defined as p < 0.05: *p < 0.0001 vs the corresponding PKCδ inhibitor-untreated cells
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(FBS) plus antibiotics. Primary cultures of human fibro-
blasts derived from healthy skin (HFs) were obtained from
patients attending the Dermatology Unit of the Sant’An-
drea Hospital of Rome; all patients were extensively
informed and their consent for the investigation was given
and collected in written form in accordance with guide-
lines approved by the management of the Sant’Andrea
Hospital. HFs were isolated and cultured as previously
described55.
For growth factors stimulation, cells were left untreated
or incubated with FGF7 (Upstate Biotechnology, Lake
Placid, NY, USA, 01–118) 100 ng/ml for 24 or 48 h at 37 °
C. To inhibit AKT or MEK1/2 or PKCδ or PKCα cells
were respectively incubated with the specific AKT inhi-
bitor 1L-6-hydroxy-methyl-chiro-inositol 2-(R)-2-O-
methyl-3-O-octadecylcarbonate (1 μM; Calbiochem,
Nottingham, UK, 124005) or with the specific MEK1/2
inhibitor PD0325901 (1 μM; Sigma-Aldrich, Saint Louis,
MO, USA, PZ0162) or with the specific PKCδ inhibitor
rottlerin (5 μM; Calbiochem, 557370) or with the specific
PKCα inhibitor Go6976 (3 μM; Calbiochem, 365250) for
1 h at 37 °C before treatment with FGF7 in the presence of
each inhibitor.
For RNA interference and PKCδ or PKCα silencing,
cells were transfected with PKCδ small interfering RNA
(PKCδ siRNA) (Santa Cruz Biotechnology, Santa Cruz,
CA, USA), or PKCα small interfering RNA (PKCα siRNA)
(Santa Cruz Biotechnology), or with an unrelated siRNA
as a control (control siRNA), using Lipofectamine 2000
Transfection Reagent (Invitrogen, Carlsbad, CA, USA)
according to the manufacturer’s protocol.
Organotypic cultures
For three-dimensional (3D) organotypic cultures, col-
lagen rafts were prepared adding 5mg/ml rat tail type I
collagen (Corning, Lowell, MA, USA) to DMEM and
Reconstitution buffer (8:1:1) as previously described56.
HFs (1 × 106) were added to 2 ml of the collagen mixture
in polycarbonate micron inserts (23 mm diameter, pore
size 0.3 µm; Corning) in 6-deep well plates (Corning). The
mixture was left to polymerize for 30min at 37 °C. After
24 h 2 × 105 HaCaT pBp or pBp-FGFR2b cells were see-
ded on the collagen gel and left to grow for a week in
complete medium added in both the top and the bottom
wells. Then, the organotypic cultures were lifted to the
air–liquid interface and cultured for further two weeks in
complete medium added or not with the specific PKCδ
inhibitor rottlerin (5 μM; Calbiochem, 557370). Then
cultures were left untreated or stimulated with FGF7
(Upstate Biotechnology) 100 ng/ml for the last 4 days.
Rafts were finally fixed in 10% formalin, embedded in
paraffin and 4 µm slices were obtained. To evaluate
organotypic thickness slices were stained with hematox-
ylin and eosin using standard procedures then bright field
images were taken with an Axiocam ICc 5 (Zeiss, Ober-
kochen, Germany) connected with an Axioplan 100
microscope (Zeiss). The organotypic culture thickness
was measured using the Axiovision software (Zeiss) and
expressed as mean µm ± standard deviation (SD). Stu-
dent’s t test was performed and significance levels have
been defined as p < 0.05.
Immunofluorescence
HaCaT clones, grown on coverslips, were fixed with 4%
paraformaldehyde in PBS for 30min at 25 °C followed by
treatment with 0.1M glycine for 20min at 25 °C and with
0.1% Triton X-100 for additional 5 min at 25 °C to allow
permeabilization. Cells were then incubated for 1 h at 25 °
C with the following primary antibodies: rabbit polyclonal
anti-K1 (1:50 in PBS, AF 87, Covance, Princeton, NJ,
USA) or mouse monoclonal anti-β1 integrin (1:1000 in
PBS; ST2–16, Santa Cruz Biotechnology). The primary
antibodies were visualized using goat anti-rabbit IgG-
Texas Red (1:200 in PBS; Jackson Immunoresearch
Laboratories, West Grove, PA, USA) or goat anti-mouse
IgG-Alexa Fluor 488 (1:200 in PBS; Life Technologies,
Carlsbad, CA, USA) antibodies for 30min at 25 °C. Nuclei
were stained with DAPI (1:1000 in PBS; Sigma). Cover-
slips were finally mounted with mowiol (Sigma) for
observation.
(see figure on previous page)
Fig. 6 PKCδ and PKCα signaling are responsible for FGF7-mediated sequential induction of KLF4 and DLX3, respectively. a Organotypic skin
equivalents of HaCaT pBp and pBp-FGFR2b clones, prepared as reported in Materials and methods section, were grown in complete medium and left
untreated or stimulated with FGF7 as above. Real time RT-PCR analysis shows a significant increase of both KLF4 and DLX3 expression upon
FGF7 stimulation, while p63 displays an opposite trend. b HaCaT pBp and HaCaT pBp-FGFR2b cells were grown up to confluence or post-confluence
in the presence or not of PKCδ and PKCα inhibitors, respectively, and stimulated with FGF7 as above. Real time RT-PCR analysis shows that KLF4 up-
regulation is mainly appreciable in confluent clones, while DLX3 induction is detectable only in post-confluent cultures. The increased expression of
KLF4 in confluent cells and that of DLX3 in post-confluent cultures are significantly dampened by PKCδi and PKCαi, respectively. Similarly to KLF4, p63
down-modulation in response to FGF7 is more evident in confluent cells and it appears impaired only by PKCδi. Results are expressed as mean
values ± SD. Student’s t test was performed and significance levels have been defined as above: a *p < 0.05 and ***p < 0.001 vs the corresponding
FGF7-unstimulated cells; **p < 0.05 vs the corresponding pBp cells; b NS and *p < 0.05 vs the corresponding FGF7-unstimulated cells; NS and **p <
0.05 vs the corresponding pBp cells; NS and ***p < 0.05 vs the corresponding PKCδ inhibitor-untreated cells; NS and ^p < 0.005 vs the corresponding
PKCα inhibitor-untreated cells
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Organotypic raft sections, obtained as above, were
deparaffinized in xylene and re-hydrated through graded
ethanols to PBS, pH 7.4. Antigen retrieval was achieved by
heating sections in target retrieval solution low pH (Dako,
Carpinteria, CA, USA) for 15min at 97 °C. Sections were
then washed with PBS and blocked using 10% bovine calf
serum and 0.2% Triton X-100 for 30 min at 25 °C before
staining with rabbit polyclonal anti-K1 (1:500 in PBS, AF
87, Covance), mouse monoclonal anti-filaggrin (1:1000 in
PBS, 15C10, Monosan Sanbio, Uden, The Netherland),
rabbit polyclonal anti-cytokeratin 5 (1:400 in PBS, Abcam,
Cambridge, UK) or mouse monoclonal anti-Ki67 (1:100 in
PBS, MIB-1, Dako) antibodies for 1 h in a humidified
chamber. The primary antibodies were visualized using
goat anti-mouse IgG-Texas Red (1:200 in PBS; Jackson
Immunoresearch Laboratories) or goat anti-rabbit IgG-
Texas Red (1:200 in PBS; Jackson Immunoresearch
Laboratories) antibodies for 30min at 25 °C. Nuclei were
stained with DAPI (1:1000 in PBS; Sigma). Sections were
permanently mounted under a coverslip. Fluorescence
signals were analyzed by conventional fluorescence or by
scanning cells in a series of sequential sections with an
ApoTome System (Zeiss) connected with an Axiovert 200
inverted microscope (Zeiss); image analysis was per-
formed by the Axiovision software (Zeiss) and images
were obtained by 3D reconstruction of the total number
of the serial optical sections. Quantitative analysis of the
fluorescence intensity was performed by the Axiovision
software (Zeiss), analyzing 10 different fields randomly
taken from three independent experiments. Quantitative
analysis of the percentage of Ki67 positive cells was
assessed counting for each sample a total of 50 cells,
randomly observed in 10 microscopic fields from three
different experiments. Results are shown as means ±
standard error (SE). Student’s t test was performed and
significance levels have been defined as p < 0.05.
Western blot analysis
Cells were lysed in a buffer containing 50 mM HEPES,
pH 7.5, 150 mM NaCl, 1% glycerol, 1% Triton X-100, 1.5
mM MgCl2, 5 mM EGTA, supplemented with protease
inhibitors (10 μg/ml aprotinin, 1 mM PMSF, 10 μg/ml
leupeptin), and phosphatase inhibitors (1 mM sodium
orthovanadate, 20 mM sodium pyrophosphate, 0.5M
NaF). A range between 20 and 50 μg of total protein was
resolved under reducing conditions by 8 or 12% SDS-
PAGE and transferred to reinforced nitrocellulose (BA-S
83, Schleider and Schuell, Keene, NH, USA). The mem-
branes were blocked with 5% nonfat dry milk in PBS 0.1%
Tween 20 and incubated with anti-DSG1 (27B2, Life
Technologies), anti-β1 integrin (ST2–16, Santa Cruz
Biotechnology), anti-involucrin (SY5, Abcam), anti-
filaggrin (15C10, Monosan), anti-p-PKCα (Ser657,
Abcam) monoclonal antibody or with anti-K1 (AF 87,
Covance), anti-Bek (C-17, Santa Cruz Biotechnology),
anti-loricrin (Covance), anti-p-PKCδ (Ser645, Santa Cruz
Biotechnology) polyclonal antibodies, all followed by
enhanced chemiluminescence detection (ECL, Amer-
sham, Alington Heights, IL, USA). The membranes were
rehydrated by being washed in PBS-Tween 20, stripped
with 100mM mercaptoethanol and 2% SDS for 30min at
55 °C, and probed again with anti-PKCδ (C-20, Santa
Cruz Biotechnology) polyclonal antibodies, anti-PKCα
monoclonal antibody (Y124, Abcam) or with anti-β-
ACTIN (AC-15, Sigma) monoclonal antibody or anti-α-
TUBULIN (2148S, Cell Signaling) polyclonal antibodies to
estimate the protein equal loading. Densitometric analysis
was performed using Quantity One Program (Bio-Rad
Laboratories, Hercules, CA, USA). Results from three
different experiments were normalized and expressed as
fold increase respect to the control value. Values from a
representative of three independent experiments were
reported in each figure.
Primers
Oligonucleotide primers necessary for target genes and
the housekeeping gene were chosen utilizing the online
tool Primer-BLAST and purchased from Invitrogen. Pri-
mers list and characteristics are reported in Supplemen-
tary Table S1. For p63 target gene, the reported primers
were designed to recognize both ΔNp63 and TAp63 α and
β isoforms. For each primer pair, we performed no-
template control and no-reverse-transcriptase control
(RT negative) assays, which produced negligible signals.
RNA extraction and cDNA synthesis
Organotypic cultures were deparaffinized and RNA was
extracted using the TRIzol method (Invitrogen) according
to manufacturer’s instructions and eluted with 0.1% die-
thylpyrocarbonate (DEPC)-treated water. Each sample
was treated with DNAase I (Invitrogen). Total RNA
concentration was quantitated by spectrophotometry; 1
μg of total RNA was used to reverse transcription using
iScriptTM cDNA synthesis kit (Bio-Rad) according to
manufacturer’s instructions.
PCR amplification and real time quantitation
Real time RT-PCR was performed using the iCycler Real
Time Detection System (iQ5 Bio-Rad) with optimized
PCR conditions. The reaction was carried out in 96-well
plate using iQ SYBR Green Supermix (Bio- Rad) adding
forward and reverse primers for each gene and 1 μl of
diluted template cDNA to a final reaction volume of 15 μl.
All assays included a negative control and were replicated
three times. The thermal cycling program was performed
as described6. Real time quantitation was performed with
the help of the iCycler IQ optical system software version
3.0a (Bio-Rad), according to the manufacturer’s manual.
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Results are reported as mean ± SD from three different
experiments in triplicate. Student’s t test was performed
and significance levels have been defined as p < 0.05.
Statistical analysis
Data were statistically analyzed with unpaired two-tailed
Student’s t test. Differences were considered significant at
the level of p < 0.05. Statistical analysis was performed by
using Microsoft Excel 2016 Spreadsheet Software
(Microsoft® Software; Redmond, Washington, United
States).
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